Effects of fibroblast growth factor 21 on the heart (Q26784095)

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE(-/-) mice.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Myocardial utilization of carbohydrate and lipids

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

https://api.crossref.org/works/10.1530%2FJOE-15-0289

1 reference

7 January 2021

Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Structural basis for fibroblast growth factor receptor activation

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

FGF21 N- and C-termini play different roles in receptor interaction and activation

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

The FGF family: biology, pathophysiology and therapy

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Exploring mechanisms of FGF signalling through the lens of structural biology

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fatty acid utilization during development of the rat

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factor 21 protects the heart from oxidative stress.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Chronic heart failure in the United States: a manifestation of coronary artery disease

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Metabolic gene expression in fetal and failing human heart

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Pathophysiological roles of FGF signaling in the heart

1 reference

https://api.crossref.org/works/10.1530%2FJOE-15-0289

7 January 2021

Identifiers

DOI

10.1530/JOE-15-0289

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

26341481

1 reference

Consolidated OpenCitations Corpus – April 2017